Figure 5.
Quantitative assessment of antioxidant efficacy in healthy controls, HFrEF patients, and 3 groups of HTx recipients. (A) plasma ascorbate; (B) Thiobartituric Acid Reactive Substances (TBARS). Values are means ± SE. (*) Significantly different from Controls; (†) Significantly different from Placebo.